Single-cell N6-methyladenosine regulator patterns guide intercellular communication of tumor microenvironment that contribute to colorectal cancer progression and immunotherapy

by An, R., Chen, S., Chu, Y., Gao, Y., Li, G., Wang, H., Wang, Y., Xie, X., Zhang, J.
Published 2022

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy

by Beers, S.A, Booth, S.G, Carter, M.J, Chee, S.J, Cleary, K.L.S, Cragg, M.S, Cutress, R.I, Dahal, L.N, Douglas, J., Foxall, R.B, French, R.R, Frendéus, B., Ghorbani, M., Glennie, M.J, Hargreaves, C.E, Hussain, K., James, S., Kemp, R.S, Liu, R., Longley, J., Macari, S., Markham, H., Müller, K.T.J, Murray, T., Oldham, R.J, Ottensmeier, C.H, Roghanian, A., Smith, R.C.G, Stopforth, R.J, Strefford, J.C, Thirdborough, S.M
Published 2022

Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment

by Chang, C.-R, Chang, W.-S.W, Chen, L.-T, Chen, T.-H, Jiang, S.-S, Liao, C.-Y, Lin, K.M.-C, Lu, W.-C, Tsai, F.-Y, Wu, T.-C
Published 2022

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

by Chittepu, V.C.S.R, Farrukh, H., Pan, C.-X, Pan, K., Xu, H., Zhu, Z.
Published 2022

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

by Bian, J., Chen, P., Lin, Y., Long, J., Sang, X., Wang, A., Wang, D., Yang, X., Zhang, H., Zhao, H., Zheng, M., Zheng, Y.
Published 2022

CHARTS: a web application for characterizing and comparing tumor subpopulations in publicly available single-cell RNA-seq data sets

by Bernstein, M.N, Burkard, M.E, Collins, M., Kendziorski, C., Ni, Z., Stewart, R.
Published 2021

Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer

by Ding, H., Feng, Z., Hu, K., Peng, Z., Ye, M.
Published 2022

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy

by Beers, S.A, Booth, S.G, Carter, M.J, Chee, S.J, Cleary, K.L.S, Cragg, M.S, Cutress, R.I, Dahal, L.N, Douglas, J., Foxall, R.B, French, R.R, Frendéus, B., Ghorbani, M., Glennie, M.J, Hargreaves, C.E, Hussain, K., James, S., Kemp, R.S, Liu, R., Longley, J., Macari, S., Markham, H., Müller, K.T.J, Murray, T., Oldham, R.J, Ottensmeier, C.H, Roghanian, A., Smith, R.C.G, Stopforth, R.J, Strefford, J.C, Thirdborough, S.M
Published 2022

BIRC5 regulates inflammatory tumor microenvironment-induced aggravation of penile cancer development in vitro and in vivo

by Li, S., Liu, S., Tian, A., Wan, Y., Zhang, G., Zhao, Y.
Published 2022

Anti-PADI4 antibody suppresses breast cancer by repressing the citrullinated fibronectin in the tumor microenvironment

by Cai, D., Chang, X., Fang, K., Liu, C., Song, X., Song, Y., Wang, Y., Zhang, N.
Published 2022